These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
581 related items for PubMed ID: 18341587
1. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D. FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587 [Abstract] [Full Text] [Related]
2. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY. Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [Abstract] [Full Text] [Related]
3. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS. Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319 [Abstract] [Full Text] [Related]
4. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T. Mol Cancer Res; 2008 Dec 01; 6(12):1852-60. PubMed ID: 19074830 [Abstract] [Full Text] [Related]
5. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY. Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429 [Abstract] [Full Text] [Related]
6. Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP. He Q, Luo X, Jin W, Huang Y, Reddy MV, Reddy EP, Sheikh MS. Oncogene; 2008 Apr 17; 27(18):2656-60. PubMed ID: 17968315 [Abstract] [Full Text] [Related]
7. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY, Kim EH, Park SS, Lim JH, Kwon TK, Choi KS. J Cell Biochem; 2008 Dec 15; 105(6):1386-98. PubMed ID: 18980244 [Abstract] [Full Text] [Related]
8. Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death. Woods DC, Liu HK, Nishi Y, Yanase T, Johnson AL. Cancer Lett; 2008 Feb 18; 260(1-2):20-7. PubMed ID: 18031928 [Abstract] [Full Text] [Related]
9. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, Yoon AR, Yun CO, Choi KS. Cancer Res; 2007 Sep 01; 67(17):8274-84. PubMed ID: 17804742 [Abstract] [Full Text] [Related]
10. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole. Goda AE, Yoshida T, Horinaka M, Yasuda T, Shiraishi T, Wakada M, Sakai T. Oncogene; 2008 May 29; 27(24):3435-45. PubMed ID: 18193086 [Abstract] [Full Text] [Related]
11. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T. Cancer Res; 2008 Nov 01; 68(21):8918-27. PubMed ID: 18974136 [Abstract] [Full Text] [Related]
13. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK. Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688 [Abstract] [Full Text] [Related]
14. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Jung EM, Park JW, Choi KS, Park JW, Lee HI, Lee KS, Kwon TK. Carcinogenesis; 2006 Oct 15; 27(10):2008-17. PubMed ID: 16613838 [Abstract] [Full Text] [Related]
16. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL. Ganten TM, Koschny R, Haas TL, Sykora J, Li-Weber M, Herzer K, Walczak H. Hepatology; 2005 Sep 15; 42(3):588-97. PubMed ID: 16037944 [Abstract] [Full Text] [Related]
17. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Zhang Y, Zhang B. Mol Cancer Res; 2008 Dec 15; 6(12):1861-71. PubMed ID: 19074831 [Abstract] [Full Text] [Related]
18. Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis. Ohtsuki T, Kikuchi H, Koyano T, Kowithayakorn T, Sakai T, Ishibashi M. Bioorg Med Chem; 2009 Sep 15; 17(18):6748-54. PubMed ID: 19682913 [Abstract] [Full Text] [Related]
19. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5. Gasparian ME, Chernyak BV, Dolgikh DA, Yagolovich AV, Popova EN, Sycheva AM, Moshkovskii SA, Kirpichnikov MP. Apoptosis; 2009 Jun 15; 14(6):778-87. PubMed ID: 19412666 [Abstract] [Full Text] [Related]
20. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Park SK, Sanders BG, Kline K. Breast Cancer Res Treat; 2010 Nov 15; 124(2):361-75. PubMed ID: 20157774 [Abstract] [Full Text] [Related] Page: [Next] [New Search]